Clinical Trials Logo

Infrapopliteal Lesions clinical trials

View clinical trials related to Infrapopliteal Lesions.

Filter by:
  • None
  • Page 1

NCT ID: NCT05971394 Recruiting - Clinical trials for Critical Limb Ischemia

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Start date: July 17, 2023
Phase: N/A
Study type: Interventional

The goal of this prospective, multicentre, single arm clinical trial is to assess the safety and effectiveness of Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™) in treating patients with infrapopliteal arterial stenosis or occlusive disease. 100 participants will be implanted with IBS Titan™, and be followed up for 1-month, 6-month and 12-month after discharge.

NCT ID: NCT04365075 Recruiting - Clinical trials for Critical Limb Ischemia

Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions.

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This study was designed to compare excimer laser combined with drug-coated baloons with angioplasty alone in the treatment of infrapopliteal lesions in patients with critical limb ischemia.

NCT ID: NCT01260870 Terminated - PAD Clinical Trials

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

Start date: August 15, 2011
Phase: Phase 2
Study type: Interventional

To evaluate the procedural safety and to identify and characterize therapeutic and functional endpoint assessments in subjects with documented critical limb ischemia who received treatment with the Cotavance Paclitaxel-Coated Balloon vs. those who received POBA only.